Sanofi Consumer Healthcare India Ltd

₹3,977.05▲ +0.6%28 Sept

📊 Stock Analysis

Market Data

Market Cap₹9,159.39 Cr.

52W High₹5,241.35

Current Price₹3,977.05

52W Low₹3,840.75

Down from 52W High24.1 %

Face Value₹10

Performance

ROCE97.42 %

ROE76.46 %

EPS (TTM)₹29.87

EPS Prev Qtr₹29.44

EPS Last Year₹27.31

EBITDA Qtr₹86 Cr.

Book Value₹151

Financial Health

Debt/Equity0.06

Debt/Profit0.08

Total Assets₹706.4 Cr.

Promoter Holding71.27 %

Earning Power48.09 %

Valuation

Stock P/E34.44

Industry P/E33.81

Price to Book26.33

Price to Sales9.64

Graham Number₹626.5

Key Metrics

Face Value

₹10

About Sanofi Consumer Healthcare India Ltd

Healthcare · Pharmaceuticals

Sanofi Consumer Healthcare India Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹10. Market cap ₹9,159.39 Cr.

Price Chart

Peer Comparison

Name	CMP	P/E	Market Cap	Div Yield	NP Qtr	Qtr Profit Var%	Sales Qtr	Qtr Sales Var%	ROCE%	Debt/Eq
Sun Pharmaceutical Industries Ltd	-	36.51	₹4,41,477.63 Cr	0.87%	₹12,172.7 Cr	-	₹59,910.52 Cr	-	18.72%	0.05
Divis Laboratories Ltd	-	86.48	₹2,53,031.38 Cr	0.31%	₹2,925 Cr	-	₹11,230 Cr	-	23.04%	0
Torrent Pharmaceuticals Ltd	-	77.67	₹1,85,216.32 Cr	0.78%	₹2,156 Cr	-	₹15,723 Cr	-	15.1%	1.76
Zydus Lifesciences Ltd	-	27.01	₹1,20,897.46 Cr	0.08%	₹4,492.2 Cr	-	₹28,591.7 Cr	-	16.76%	0.43
Cipla Ltd	-	33.28	₹1,12,201.64 Cr	0.94%	₹3,364.84 Cr	-	₹28,324.4 Cr	-	13.24%	0.01
Laurus Labs Ltd	-	99.31	₹1,08,698.22 Cr	0.06%	₹1,090.76 Cr	-	₹7,269.64 Cr	-	20.79%	0.45
Dr Reddys Laboratories Ltd	-	31.6	₹1,02,039.12 Cr	0.65%	₹3,183.3 Cr	-	₹33,227.9 Cr	-	10.05%	0.17
Mankind Pharma Ltd	-	49.29	₹1,00,752.43 Cr	0.04%	₹2,067.57 Cr	-	₹14,737.88 Cr	-	13.95%	0.38
Aurobindo Pharma Ltd	-	26.56	₹97,814.24 Cr	0.24%	₹3,710.8 Cr	-	₹34,935.29 Cr	-	12.75%	0.2
Lupin Ltd	-	16.64	₹94,274.49 Cr	0.87%	₹5,550.99 Cr	-	₹29,966.58 Cr	-	27.95%	0.26
Glenmark Pharmaceuticals Ltd	-	36.67	₹65,922.11 Cr	0.11%	₹1,797.81 Cr	-	₹17,736.56 Cr	-	24.78%	0.25
Alkem Laboratories Ltd	-	28.65	₹61,804.34 Cr	1.03%	₹2,206.3 Cr	-	₹15,081.28 Cr	-	19.75%	0.12
Biocon Ltd	-	110.29	₹61,113.53 Cr	0.13%	₹416.4 Cr	-	₹17,321.1 Cr	-	2.87%	0.43
Abbott India Ltd	-	35.22	₹56,860.69 Cr	1.78%	₹1,614.68 Cr	-	₹7,004.38 Cr	-	45.73%	0
Glaxosmithkline Pharmaceuticals Ltd	-	46.73	₹49,091.33 Cr	1.97%	₹1,068.15 Cr	-	₹3,954.94 Cr	-	64.07%	0
Ipca Laboratories Ltd	-	36.13	₹48,712.48 Cr	0.31%	₹1,379.76 Cr	-	₹10,125.58 Cr	-	21.48%	0.09
Anthem Biosciences Ltd	-	83.03	₹47,949.68 Cr	0.23%	₹575.95 Cr	-	₹2,002.34 Cr	-	25.5%	0.02
Gland Pharma Ltd	-	42.26	₹47,764.08 Cr	0.69%	₹1,128.8 Cr	-	₹6,725.3 Cr	-	15.21%	0.02
Ajanta Pharma Ltd	-	38.87	₹44,109.77 Cr	0.79%	₹1,134.88 Cr	-	₹5,776.17 Cr	-	31.81%	0.05
J B Chemicals & Pharmaceuticals Ltd	-	53.3	₹38,730.77 Cr	0.39%	₹709.46 Cr	-	₹4,147.79 Cr	-	23.03%	0

Quarterly Results

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	233.9	251	229.2	235.7
↳ QoQ Growth	-	+7.3%	-8.7%	+2.8%
Expenses	152.2	164.6	143.6	149.7
Operating Profit	81.7	86.4	85.6	86
OPM %	34.93%	34.42%	37.35%	36.49%
Other Income	3	4.6	5.6	6.3
Interest	0.6	0.5	0.5	0.4
Depreciation	3.3	3.4	3.2	3.3
EBITDA	85	89.8	88.8	89.3
EBITDA Margin %	36.34%	35.78%	38.74%	37.89%
Profit Before Tax	84.1	90.5	90.7	91.9
Tax %	25.21%	26.52%	25.25%	25.14%
Net Profit	62.9	66.5	67.8	68.8
↳ QoQ Growth	-	+5.7%	+2.0%	+1.5%
EPS	27.31	28.87	29.44	29.87

Balance Sheet

	Mar 2025	Mar 2026	Mar 2027
Equity Capital	23	23	23
Reserves	250	361	324.9
Borrowings	20.3	0	20.8
Other Liabilities	138	163	337.7
Total Liabilities	431.3	547	706.4
Fixed Assets	27.2	35.9	29.5
CWIP	0.7	0	0
Investments	0	0	0
Other Assets	403.4	511.1	676.9
Total Assets	431.3	547	706.4

Cash Flows

	Mar 2026
Cash from Operating Activity	174.8
Cash from Investing Activity	7.6
Cash from Financing Activity	-134.5
Net Cash Flow	47.9

Shareholding Pattern

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters %	71.27%	71.27%	71.27%	71.27%
FIIs %	2.94%	2.83%	2.76%	2.6%
DIIs %	17.21%	17.33%	17.57%	17.86%
Public %	6.26%	6.25%	6.26%	6.18%
No. of Shareholders	48,808	48,075	48,418	47,511